Bray Capital Advisors’s Chemours CC Stock Holding History

Bray Capital Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-41	Closed	-$1K	–	275
2019 Q3	$1K	Hold	41	–	–	﹤0.01%	341
2019 Q2	$1K	Hold	41	–	–	﹤0.01%	361
2019 Q1	$2K	Hold	41	–	–	﹤0.01%	337
2018 Q4	$1K	Hold	41	–	–	﹤0.01%	353
2018 Q3	$2K	Hold	41	–	–	﹤0.01%	346
2018 Q2	$2K	Hold	41	–	–	﹤0.01%	337
2018 Q1	$2K	Buy	+41	New	+$2.05K	﹤0.01%	339
2015 Q4	–	Sell	-40	Closed	–	–	159
2015 Q3	$0	Buy	+40	New	+$419	﹤0.01%	394

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bray Capital Advisors's CC Position: Q4 2019 in Review

Bray Capital Advisors sold out of Chemours (CC) in Q4 2019, closing a stake of 41 shares — an estimated $1K sold.

Bray Capital Advisors first reported a position in CC in Q3 2015 and held it in 8 quarters. The position peaked at $2K in Q1 2019. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

Bray Capital Advisors reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
Bray Capital Advisors sold 41 Chemours shares in Q4 2019, an estimated $1K.
Bray Capital Advisors first reported a position in Chemours in Q3 2015 and held it in 8 quarters.
Bray Capital Advisors's Chemours position peaked at $2K in Q1 2019.
439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Bray Capital Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.